CION Ameerpet
Primary CNS lymphoma (PCNSL) is a rare brain cancer that behaves like a lymphoma, not a glioma. It responds to medicine that reaches the brain — so the plan is very different from most brain tumours.
Primary central nervous system lymphoma (PCNSL) — also called primary CNS lymphoma or brain lymphoma — is a rare, aggressive cancer that starts in the immune (lymphoid) cells within the brain, spinal cord, eyes, or the fluid around them. Unlike most lymphomas, it does not travel around the body; it stays inside the central nervous system. Almost every case is a subtype called diffuse large B-cell lymphoma.
Here is the single most important idea on this page: CNS lymphoma is a blood-cell cancer, not a glioma. That one fact changes everything about how it is treated. Where a brain tumour like a glioma is often removed by surgery, PCNSL is chemo-sensitive — it melts away with the right medicine. So the treatment is built around drug therapy that reaches the brain, delivered directly by CION's medical oncology team, rather than tumour-removal surgery.
Steroids can make CNS lymphoma almost disappear on a scan within days — which is why the European Association of Neuro-Oncology (EANO) advises that, whenever it is safe, the diagnostic biopsy should be taken before steroids are started. Steroids given first can leave the biopsy sample non-diagnostic, so the pathologist cannot confirm lymphoma and treatment is delayed.
These three look similar on an early scan but are completely different diseases — and the treatment plans have almost nothing in common. Getting the diagnosis right is what protects you from the wrong operation.
A lymphoid (blood-cell) cancer that lives in the brain. Not removed by surgery — biopsy is diagnostic only. Highly sensitive to high-dose methotrexate-based chemotherapy, and often to radiation. Managed mainly by a medical oncology team.
Grows from the brain's own support cells. Treatment usually begins with maximum safe surgical removal, followed by radiation and chemotherapy where needed. This is the classic brain tumour treatment pathway.
A solid cancer that has spread to the brain from elsewhere — commonly lung, breast, or kidney. Treated with focused radiation or surgery to the brain lesions while systemic therapy continues for the original cancer.
PCNSL often develops over days to a few weeks — faster than many slow-growing tumours. Symptoms depend on where in the brain it sits, but the most common patterns include:
Important: these symptoms are far more often caused by common, non-cancerous conditions. But when they are new, persistent, and steadily progressing — especially confusion or one-sided weakness building over days to weeks — a brain MRI with contrast is warranted. Speak to a CION specialist if a scan has already found a lesion suspicious for lymphoma.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
CION Ameerpet
CION Kukatpally
CION L.B. Nagar
CION Tolichowki
CION Masab Tank
CION Banjara Hills
CION Kompally
CION Balanagar
CION Siddipet
CION Sangareddy
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centreTravelling for treatment? We may have a centre right where you are.
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationShare your name and number — we'll call you back within 30 minutes to schedule your consultation.
Whether the diagnosis is new, or you want to confirm the treatment sequence before starting chemotherapy, CION's medical oncology team is here — with 150+ years combined experience and 45-minute consultations.
Because PCNSL is treated so differently from other brain tumours, a precise diagnosis before any treatment is essential. CION's diagnostic pathway confirms the lymphoma and maps everywhere it may be hiding within the nervous system.
MRI with gadolinium contrast is the key imaging test. CNS lymphoma often appears as one or more strongly enhancing lesions, frequently deep in the brain near the fluid-filled ventricles. Imaging of the spine is added because lymphoma can seed along the nervous system.
A small, image-guided needle biopsy confirms the diagnosis. Crucially, the tumour is not surgically removed — resection does not improve survival in PCNSL and adds risk. At CION this biopsy is coordinated with accredited neurosurgical partners. Wherever it is safe, the biopsy is taken before steroids, because steroids can shrink the lymphoma and make the sample non-diagnostic.
Full staging usually adds a dilated eye examination (lymphoma can involve the eyes), a lumbar puncture to check the cerebrospinal fluid for lymphoma cells when it is safe to do so, and blood tests including an HIV test — because immune status shapes the treatment plan. This complete workup follows NCCN and EANO guidance so the plan is built on the full picture from day one.
Primary CNS lymphoma is one of the more chemo-responsive brain cancers. High-dose methotrexate — chemotherapy given at doses high enough to cross the blood-brain barrier — is the backbone of treatment recommended by both NCCN and EANO, and many patients respond within the first cycles. This is why medical (drug) therapy, delivered directly by CION, sits at the centre of care rather than surgery.
PCNSL treatment runs in two broad phases — induction (to drive the disease into remission) and consolidation (to keep it there in patients fit enough). CION's medical oncology and radiation teams deliver this care directly, with every plan set by a multidisciplinary tumour board.
Throughout treatment CION provides the supportive care that matters day to day — steroid and seizure management, nutrition, and rehabilitation. Any radiosurgery or specialist neurosurgical input is coordinated with accredited partners. Book a free consultation to talk through the right sequence for your situation, or call 18002028726.
A CNS lymphoma diagnosis moves quickly, and the first few decisions carry a lot of weight. A second opinion is especially worthwhile in these situations:
Every brain lymphoma case at CION is reviewed by a multidisciplinary tumour board — medical oncology, radiation oncology, radiology, and pathology together — before a plan is finalised. Because PCNSL is a lymphoma, our approach draws on CION's wider lymphoma expertise alongside neuro-oncology care. Decisions are made for healing, not billing, and your cost estimate is explained transparently after your consultation.
Get a free written second opinion from CION's tumour board — particularly valuable before steroids are started, or before your first cycle of chemotherapy begins.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.Primary central nervous system lymphoma (PCNSL) is a rare, aggressive non-Hodgkin lymphoma that begins in the brain, spinal cord, eyes, or the fluid around the brain — and, unlike most lymphomas, stays confined to the central nervous system. Almost all cases are a subtype called diffuse large B-cell lymphoma. Because it is a lymphoma and not a glioma, it is not treated with tumour removal surgery. Instead it responds to drug therapy that reaches the brain — most importantly high-dose methotrexate chemotherapy — and, in selected patients, radiation. Getting the diagnosis and treatment sequence right early matters a great deal, so a specialist review is worthwhile.
A glioma grows from the brain's own support cells; a brain metastasis is a solid cancer that spread from elsewhere. Primary CNS lymphoma is neither — it is a blood-cell (lymphoid) cancer that happens to live in the brain. That difference changes the whole plan. Gliomas and single metastases are often removed surgically; PCNSL is chemo-sensitive, so surgery is used only to take a small biopsy, not to remove the tumour. High-dose methotrexate-based chemotherapy is the backbone of treatment, and many patients respond quickly. This is why an accurate tissue diagnosis before any surgery is so important.
Steroids (such as dexamethasone) shrink CNS lymphoma dramatically and quickly — sometimes the tumour almost vanishes on the next scan. That sounds good, but it can make the biopsy sample non-diagnostic, so the pathologist cannot confirm lymphoma. Whenever it is safe to do so, the diagnostic biopsy should be taken before steroids are started. If steroids have already been given and the diagnosis is unclear, the team may pause them and repeat imaging. If you or a family member has a suspected CNS lymphoma, ask the treating team about biopsy timing before steroids — it is a decision that affects the whole pathway.
The cornerstone is high-dose methotrexate, an antimetabolite chemotherapy given at doses high enough to cross the blood-brain barrier and reach lymphoma cells in the brain — usually combined with other agents in a multi-drug regimen. This induction phase aims to put the disease into remission. Selected fit patients may then have consolidation, which can include further chemotherapy, an autologous stem-cell transplant, or radiation to the whole brain, depending on age, kidney function, and response. Anti-CD20 antibody therapy is often added. CION's medical oncology team delivers this systemic treatment directly, guided by a multidisciplinary tumour board.
No. Unlike a glioma, PCNSL is not removed by surgery. Trying to resect it does not improve survival and adds risk. The only surgery needed is a stereotactic needle biopsy — a small, image-guided sample to confirm the diagnosis — which CION coordinates with accredited neurosurgical partners. Occasionally surgery is needed urgently to relieve dangerous pressure. Once lymphoma is confirmed, the disease is controlled with chemotherapy and, if required, radiation. You can read more about how chemotherapy is used for brain tumours on our dedicated page.
Often, yes. PCNSL can involve the eyes (vitreoretinal lymphoma) and the fluid around the brain and spine, so staging usually includes a dilated eye examination by an ophthalmologist and a lumbar puncture (spinal tap) to check the cerebrospinal fluid for lymphoma cells — when it is safe to do so. An MRI of the whole brain and spine with contrast, blood tests, and an HIV test are also standard, because immune status affects treatment. These steps map the full extent of disease so the plan is complete from the start. CION arranges this staging as part of the diagnostic pathway.
PCNSL is serious, but it is one of the more chemo-responsive brain cancers, and outcomes have improved with modern high-dose methotrexate regimens. Prognosis depends heavily on age, general fitness, kidney function, whether the disease responds to induction, and whether consolidation is possible — so published survival figures vary widely and no single number fits every person. Younger, fit patients who achieve a good response and receive consolidation generally do better. Rather than a headline statistic, what matters is a plan built for your specific situation. Speak to a CION specialist for an honest, personalised discussion.
Browse our complete guide to brain tumours and brain cancer — symptoms, scans, tumour types, treatment, prognosis and life after treatment. Tap any topic to read more.